Figures & data
Figure 1 Strategy for development of next-generation allergy vaccines. Next-generation allergen-specific immunotherapy for typeI allergies, including JC pollinosis, that exhibits high efficiency, improved safety, and patient convenience, has to be developed through modification of allergens and use of suitable adjuvants. The administration route also has to be taken into account.
